An update from Lixte Biotechnology Holdings ( ($LIXT) ) is now available. On December 17, 2025, Lixte Biotechnology Holdings amended its ...

Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ovarian cancer diagnosis this year.

Here are the top 5 ovarian cancer articles of 2025; stay up-to-date with all the ovarian cancer content from The American ...

Ovarian cancer, often a \"silent killer,\" is the 8th most common cancer in women globally and the third in India. Early ...

Cirtuvivint is a selective pan-CLK, pan-DYRK inhibitor that modulates alternative RNA splicing, including transcripts involved in oncogenic pathways. Preclinical studies have shown that CLK/DYRK ...

Although frontline maintenance treatment with fuzuloparib monotherapy produced a progression-free survival (PFS) benefit in patients with newly diagnosed advanced ovarian cancer, the addition of ...

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to hormone therapy? In a recently published study, she shared a new theory as to ...

The World Ovarian Cancer Coalition announced that a groundbreaking international study, "Experiences of Women with Ovarian Cancer in 22 Low- and Middle- Income Countries (Every Wo ...

A recent study has found that two cannabis derivatives may aid in ovarian cancer treatment. The research indicates that CBD ...

Nelsen says while recovering from surgery, the TV was showing the Boston marathon and that lit a spark in her soul.